RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Crista Galli Ventures
C

Crista Galli Ventures portfolio

Crista Galli Ventures has 2 portfolio companies on record at Recent Funding.

Website: cristagalli.com.
Type: Family office.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $9.15M.
Latest deal: QUIBIM · Jul 21, 2020.
About this page

It is a family office based in London, GB, founded in 2019. Its most recent investment on record is QUIBIM's $9.15M Seed round in July 2020, alongside Adara Ventures, Angels Capital, APEX Ventures and 3 others. By category, its portfolio leans toward Health and bio (2) and Stablecoins (1).

About Crista Galli Ventures

Firm type: Family office.
Headquarters: London, GB.
Founded: 2019.
Stages: Pre-Seed, Seed, Series A.
Sectors: AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.

What Crista Galli Ventures invests in

How Crista Galli Ventures invests

StageDealsCapital in rounds
Seed 1 100%$9.15M

Crista Galli Ventures portfolio companies

CompanyRound with Crista Galli VenturesTotal raisedLatest raise
QQUIBIM
Health and bio
Seed · $9.15M$59.73MFeb 25, 2025
Series A
CCardiaTec Biosciences
Stablecoins
backerundisclosed—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Crista Galli Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Crista Galli Ventures, which is a subset of its real portfolio. API: /api/v1/investors/crista-galli-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy